<DOC>
	<DOCNO>NCT02130323</DOCNO>
	<brief_summary>OBJECTIVE : The standard care high grade cervical intraepithelial neoplasia grade 2 3 ( CIN 2-3 ) excision cervical transformation zone way loop electrosurgical excision procedure ( LEEP ) cold knife conization ( CKC ) . However , recognize procedure increase risk pre-term labor woman still desire conceive . Recent study show medical treatment Imiquimod , topical immune response modulator , significant effect histological regression CIN 2-3 compare placebo . The investigator propose treatment Imiquimod may preferable offer similar outcome histological regression compare excision ablation potentially avoid reduce number surgical procedure place risk future pregnancy .</brief_summary>
	<brief_title>Topical Imiquimod vs. LEEP Women With Carcinoma In-situ Cervix</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Healthy woman old age 21 , military civilian Negative pregnancy test result Confirmed CIN 23 cervical biopsy negative endocervical curettage ( ECC ) satisfactory colposcopy visualize complete transformation zone cervix . The patient available San Diego area 6 month enrollment complete clinic visit follow . Positive CIN 23 ECC Presence cancer Pregnancy lactation Immunocompromised ( systemic lupus erythematosus , kidney transplant ) Hepatitis Hypersensitivity Imiquimod Ulcerative colitis Crohn 's disease Human Immunodeficiency virus</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cervical intraepithelial neoplasia , Imiquimod</keyword>
</DOC>